Phase III PEMPHIX study shows Roche’s MabThera/Rituxan (rituximab) superior to mycophenolate mofetil in patients with pemphigus vulgaris

NEXT STORY
Immunicum AB (publ) Announces Nomination Committee for AGM 2020
PREV STORY
Telix Pharmaceuticals and GE Healthcare: Maximising 68Ga Supply for Prostate Cancer Imaging
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Solitaire(TM) Stent Retriever Study Validates Outcomes and Real-World Application of Stroke Treatment Best Practices

Economic Study Finds Solitaire Stent Retriever Highly Cost-Effective DUBLIN and HOUSTON - Feb. 23, ...

author_avatar
NASDAQ Market News

PositiveID Commences Production of Next Generation Caregiver Thermometer with Bluetooth Capability

DELRAY BEACH, Fla., Dec. 06, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life ...

author_avatar
NASDAQ Market News

Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers

                                                                  NANOBIOTIX PARTNERS WITH WEILL CORNELL MEDICINE ON PRE-CLINICAL STUDIES TO EVALUATE THE IMPACT ...

author_avatar
NASDAQ Market News